← Back to Patent Explorer
US4328202A Expired / Lapsed US ⏱️ 0.0 years remaining

Ionic 5-C-substituted 2,4,6-triiodoisophthalic acid derivatives

Assignee: Bayer Pharma AG
•
Filing: 1981-01-09
•
Granted: 1982-05-04
•
Expires: 2001-01-09
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Ionic compounds of the formula <IMAGE> wherein X is -CONR1R2, -CH2NHxAcyl or -CH2OH; Y is -NR3R4, -NHxAcyl or OR5; R1, R2, R3 and R4 can be identical or different, and each is hydrogen, C1-6- alkyl or C2-8-alkyl substituted by 1-5 OH groups and/or by one C1-3-alkoxy group, R5 is C1-6 alkyl or C2-8-alkyl substituted by 1-5 OH groups and/or by one C1-3-alkoxy group, and Acyl, which can be the same or different in X and Y, is C2-6-alkanoyl or C2-6-alkanoyl substituted by 1-4 OH groups and/or by one C1-3-alkoxy group, or a physiologically compatible salt thereof with an inorganic or organic base, have valuable properties as X-ray contrast agents.

Inventors

  • 👤 Heinz Gries
  • 👤 Heinrich Pfeiffer
  • 👤 Ulrich Speck
  • 👤 Wolfgang Muetzel

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-29 17:05
CPC Classifications
C; C07; C07C; C07C233/00; C07C233/90; C07C233/92; C07C233/64; C07C233/65; C07C233/67; C07C233/68; C07C233/69; C07C237/00; C07C237/28; C07C237/42; Y; Y10; Y10S; Y10S430/00; Y10S430/167; Y10S430/168

Claims Analysis

Total Claims: 23
Claim 1
Independent Claim 138 words
A compound of the formula ##STR7## wherein X is --CONR 1 R 2 , --CH 2 NH.Acyl or --CH 2 CH; Y is --NR 3 R 4 , --NH.Acyl or OR 5 ; R 1 , R 2 , R 3 and R 4 can be identical or different, and each is hydrogen, C 1-6 -alkyl or C 2-8 -alkyl substituted by 1-5 OH groups and/or by one C 1-3 -alkoxy group; R 5 is C 1-6 alkyl or C 2-8 -alkyl substituted by 1-5 OH groups and/or by one C 1-3 -alkoxy group; Acyl which can be the same or different in X and Y, is C 2-6 -alkanoyl or C 2-6 -alkanoyl substituted by 1-4 OH groups and/or by one C 1-3 -alkoxy group or a physiologically compatible salt thereof with an inorganic or organic base.
Claim 2
Dependent Claim 138 words
A compound of the formula ##STR7## wherein X is --CONR 1 R 2 , --CH 2 NH.Acyl or --CH 2 CH; Y is --NR 3 R 4 , --NH.Acyl or OR 5 ; R 1 , R 2 , R 3 and R 4 can be identical or different, and each is hydrogen, C 1-6 -alkyl or C 2-8 -alkyl substituted by 1-5 OH groups and/or by one C 1-3 -alkoxy group; R 5 is C 1-6 alkyl or C 2-8 -alkyl substituted by 1-5 OH groups and/or by one C 1-3 -alkoxy group; Acyl which can be the same or different in X and Y, is C 2-6 -alkanoyl or C 2-6 -alkanoyl substituted by 1-4 OH groups and/or by one C 1-3 -alkoxy group or a physiologically compatible salt thereof with an inorganic or organic base.
Claim 3
Dependent Claim 7 words
5-Carbamoyl-3-[N-methyl-N-(2-hydroxyethyl)carbamoyl]-2,4,6-triiodobenzoic acid, a compound of claim 1.
Claim 4
Dependent Claim 7 words
5-Carbamoyl-2,4,6-triiodoisophthalamic acid, a compound of claim 1.
Claim 5
Dependent Claim 7 words
5-Carbamoyl-3-[N-(2-hydroxyethyl)carbamoyl]-2,4,6-triiodobenzoic acid, a compound of claim 1.
Claim 6
Dependent Claim 7 words
5-Carbamoyl-3-N-methylcarbamoyl-2,4,6-triiodobenzoic acid, a compound of claim 1.
Claim 7
Dependent Claim 7 words
5-Carbamoyl-3-N,N-dimethylcarbamoyl-2,4,6-triiodobenzoic acid, a compound of claim 1.
Claim 8
Dependent Claim 7 words
5-Carbamoyl-3-acetylaminomethyl-2,4,6-triiodobenzoic acid, a compound of claim 1.
Claim 9
Dependent Claim 7 words
5-Carbamoyl-3-hydroxymethyl-2,4,6-triiodobenzoic acid, a compound of claim 1.
Claim 10
Dependent Claim 7 words
3,5-Bis(N-methylcarbamoyl)-2,4,6-triiodobenzoic acid, a compound of claim 1.
Claim 11
Dependent Claim 7 words
3,5-Bis[N-(2-hydroxyethyl)carbamoyl]-2,4,6-triiodobenzoic acid, a compound of claim 1.
Claim 12
Dependent Claim 7 words
5-N-Methylcarbamoyl-3-[N-(2-hydroxyethyl)carbamoyl]-2,4,6-triiodobenzoic acid, a compound of claim 1.
Claim 13
Dependent Claim 7 words
3-N,N-Dimethylcarbamoyl-5-[N-(2,3-dihydroxypropyl)carbamoyl]-2,4,6-triiodobenzoic acid, a compound of claim 1.
Claim 14
Dependent Claim 7 words
5-Acetylaminocarbonyl-3-N,N-dimethylcarbamoyl-2,4,6-triiodobenzoic acid, a compound of claim 1.
Claim 15
Dependent Claim 9 words
5-N-Methylcarbamoyl-2,4,6-triiodoisophthalic acid mono-(2,3-dihydroxypropyl) ester, a compound of claim 1.
Claim 16
Dependent Claim 7 words
5-Carbamoyl-3-[N-(2-methoxyethyl)carbamoyl]-2,4,6-triiodobenzoic acid, a compound of claim 1.
Claim 17
Dependent Claim 14 words
A compound of claim 1, wherein R 1 -R 5 are ethyl or methyl.
Claim 18
Dependent Claim 19 words
A compound of claim 1, wherein R 1 -R 5 are C 2-4 alkyl substituted by 1-3 OH groups.
Claim 19
Dependent Claim 20 words
A compound of claim 1, wherein acyl is C 2-4 alkanoyl or C 2-4 alkanoyl substituted by 1-3 OH groups.
Claim 20
Dependent Claim 37 words
An X-ray contrast medium comprising an amount of a compound of claim 1 effective to make the medium opaque to X-rays after it has been administered to a host undergoing X-ray diagnosis, and a pharmaceutically acceptable carrier.
Claim 21
Dependent Claim 19 words
The X-ray contrast medium of claim 19 wherein the amount of opaque agent is 50-400 mg I/ml of medium.
Claim 22
Dependent Claim 56 words
A method of rendering an inner cavity of a host opaque to X-rays, comprising administering an X-ray contrast medium of claim 19 to the host in such a manner that it passes through the inner cavity and in such an amount that, when the medium reaches the inner cavity, it renders the cavity opaque to X-rays.
Claim 23
Dependent Claim 37 words
A method of conducting urography or computer tomography on a patient in need of the same which comprises first administering an X-ray contrast medium in accordance with claim 21 and then exposing the patient to diagnostic X-raying.

References Cited (Backward Citations)

US3622616A Cited
US3819821A Cited
US4107286A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1985-05-03 1985-11-02 1986-05-04 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1989-05-03 1989-11-02 1990-05-04 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1993-05-03 1993-11-02 1994-05-04 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag